Effects of a WHO-guided digital health intervention for depression in Syrian refugees in Lebanon: A randomized controlled trial.
Journal
PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
11
10
2021
accepted:
19
05
2022
entrez:
23
6
2022
pubmed:
24
6
2022
medline:
28
6
2022
Statut:
epublish
Résumé
Most displaced people with mental disorders in low- and middle-income countries do not receive effective care, and their access to care has deteriorated during the Coronavirus Disease 2019 (COVID-19) pandemic. Digital mental health interventions are scalable when digital access is adequate, and they can be safely delivered during the COVID-19 pandemic. We examined whether a new WHO-guided digital mental health intervention, Step-by-Step, in which participants were supported by a nonspecialist helper, was effective in reducing depression among displaced people in Lebanon. We conducted a single-blind, 2-arm pragmatic randomized clinical trial, comparing guided Step-by-Step with enhanced care as usual (ECAU) among displaced Syrians suffering from depression and impaired functioning in Lebanon. Primary outcomes were depression (Patient Health Questionnaire, PHQ-9) and impaired functioning (WHO Disability Assessment Schedule-12, WHODAS) at posttreatment. Secondary outcomes included subjective well-being, anxiety, post-traumatic stress, and self-described problems. A total of 569 displaced people from Syria with depression (PHQ-9 ≥ 10) and impaired functioning (WHODAS > 16) were randomized to Step-by-Step (N = 283; lost to follow-up: N = 167) or ECAU (N = 286; lost to follow-up: 133). Participants were considered to be lost to follow-up when they did not fill in the outcome measures at posttest or follow-up. Recruitment started on December 9, 2019 and was completed on July 9, 2020. The last follow-up assessments were collected in December 2020. The study team had access to the online platform, where they could see treatment arm assignment for each participant. All questionnaires were completed by participants online. Intention-to-treat (ITT) analyses showed intervention effects on depression (standardized mean differences [SMDs]: 0.48; 95% CI: 0.26; 0.70; p < 0.001), impaired functioning (SMD: 0.35; 95% CI: 0.14; 0.56; p < 0.001), post-traumatic stress (SMD: 0.36; 95% CI: 0.16; 0.56; p < 0.001), anxiety (SMD: 0.46; 95% CI: 0.24; 0.68; p < 0.001), subjective well-being (SMD: 0.47; 95% CI: 0.26; 0.68; p < 0.001), and self-identified personal problems (SMD: 0.49; 95% CI 0.28; 0.70; p < 0.001). Significant effects on all outcomes were maintained at 3 months follow-up. During the trial, one serious adverse event occurred, unrelated to the intervention. The main limitation of the current trial is the high dropout rate. In this study, we found that a guided, digital intervention was effective in reducing depression in displaced people in Lebanon. The guided WHO Step-by-Step intervention we examined should be made available to communities of displaced people that have digital access. ClinicalTrials.gov NCT03720769.
Sections du résumé
BACKGROUND
Most displaced people with mental disorders in low- and middle-income countries do not receive effective care, and their access to care has deteriorated during the Coronavirus Disease 2019 (COVID-19) pandemic. Digital mental health interventions are scalable when digital access is adequate, and they can be safely delivered during the COVID-19 pandemic. We examined whether a new WHO-guided digital mental health intervention, Step-by-Step, in which participants were supported by a nonspecialist helper, was effective in reducing depression among displaced people in Lebanon.
METHODS AND FINDINGS
We conducted a single-blind, 2-arm pragmatic randomized clinical trial, comparing guided Step-by-Step with enhanced care as usual (ECAU) among displaced Syrians suffering from depression and impaired functioning in Lebanon. Primary outcomes were depression (Patient Health Questionnaire, PHQ-9) and impaired functioning (WHO Disability Assessment Schedule-12, WHODAS) at posttreatment. Secondary outcomes included subjective well-being, anxiety, post-traumatic stress, and self-described problems. A total of 569 displaced people from Syria with depression (PHQ-9 ≥ 10) and impaired functioning (WHODAS > 16) were randomized to Step-by-Step (N = 283; lost to follow-up: N = 167) or ECAU (N = 286; lost to follow-up: 133). Participants were considered to be lost to follow-up when they did not fill in the outcome measures at posttest or follow-up. Recruitment started on December 9, 2019 and was completed on July 9, 2020. The last follow-up assessments were collected in December 2020. The study team had access to the online platform, where they could see treatment arm assignment for each participant. All questionnaires were completed by participants online. Intention-to-treat (ITT) analyses showed intervention effects on depression (standardized mean differences [SMDs]: 0.48; 95% CI: 0.26; 0.70; p < 0.001), impaired functioning (SMD: 0.35; 95% CI: 0.14; 0.56; p < 0.001), post-traumatic stress (SMD: 0.36; 95% CI: 0.16; 0.56; p < 0.001), anxiety (SMD: 0.46; 95% CI: 0.24; 0.68; p < 0.001), subjective well-being (SMD: 0.47; 95% CI: 0.26; 0.68; p < 0.001), and self-identified personal problems (SMD: 0.49; 95% CI 0.28; 0.70; p < 0.001). Significant effects on all outcomes were maintained at 3 months follow-up. During the trial, one serious adverse event occurred, unrelated to the intervention. The main limitation of the current trial is the high dropout rate.
CONCLUSIONS
In this study, we found that a guided, digital intervention was effective in reducing depression in displaced people in Lebanon. The guided WHO Step-by-Step intervention we examined should be made available to communities of displaced people that have digital access.
TRIAL REGISTRATION
ClinicalTrials.gov NCT03720769.
Identifiants
pubmed: 35737665
doi: 10.1371/journal.pmed.1004025
pii: PMEDICINE-D-21-04285
pmc: PMC9223343
doi:
Banques de données
ClinicalTrials.gov
['NCT03720769']
Types de publication
Journal Article
Pragmatic Clinical Trial
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1004025Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Commentaires et corrections
Type : ErratumIn
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Front Psychiatry. 2020 Feb 12;10:986
pubmed: 32116815
Lancet. 2020 Oct 31;396(10260):1380-1382
pubmed: 32919521
BMC Med. 2014 Nov 24;12:228
pubmed: 25420518
Int J Methods Psychiatr Res. 2003;12(2):85-91
pubmed: 12830302
World Psychiatry. 2018 Feb;17(1):90-101
pubmed: 29352530
Front Psychiatry. 2019 Jan 25;9:663
pubmed: 30740065
PLoS One. 2020 Jul 6;15(7):e0234349
pubmed: 32628678
World Psychiatry. 2019 Oct;18(3):325-336
pubmed: 31496095
JMIR Res Protoc. 2021 Jan 28;10(1):e21585
pubmed: 33507158
JAMA Psychiatry. 2019 Jul 1;76(7):700-707
pubmed: 30994877
Lancet. 2019 Jul 20;394(10194):240-248
pubmed: 31200992
BMC Public Health. 2021 Jan 26;21(1):217
pubmed: 33499834
PLoS One. 2014 Jul 16;9(7):e100674
pubmed: 25029507
Mhealth. 2018 Aug 13;4:34
pubmed: 30225240
Soc Psychiatry Psychiatr Epidemiol. 2021 Mar;56(3):475-484
pubmed: 32789561
J Anxiety Disord. 2018 Apr;55:70-78
pubmed: 29422409
World Psychiatry. 2020 Jun;19(2):251-252
pubmed: 32394577
Psychiatry Res. 2016 May 30;239:245-52
pubmed: 27031595
Evid Based Ment Health. 2022 May 16;:
pubmed: 35577536
N Engl J Med. 1988 Jun 30;318(26):1728-33
pubmed: 3374545
J Affect Disord. 2017 Dec 1;223:28-40
pubmed: 28715726
Psychiatry Res. 2016 May 30;239:124-30
pubmed: 27137973
Br J Psychiatry. 2017 Feb;210(2):119-124
pubmed: 27908899
Eval Program Plann. 1979;2(3):197-207
pubmed: 10245370
Front Psychiatry. 2018 Aug 28;9:393
pubmed: 30210373
Internet Interv. 2021 Mar 04;24:100380
pubmed: 33747798
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Glob Ment Health (Camb). 2018 Nov 27;5:e39
pubmed: 30637112
BMC Med. 2018 Mar 13;16(1):40
pubmed: 29530041